Early Lumbar Drainage Combined With Intrathecal Urokinase Injection for Treatment of Severe Aneurysmal SAH (LD-ITUK)

PHASE4RecruitingINTERVENTIONAL
Enrollment

424

Participants

Timeline

Start Date

March 28, 2024

Primary Completion Date

January 30, 2026

Study Completion Date

June 30, 2026

Conditions
Aneurysmal Subarachnoid Hemorrhage
Interventions
DRUG

Urokinase

On the basis of standard treatment for severe neurological conditions, within 24 hours of aneurysm treatment, lumbar drainage combined with intrathecal urokinase injection was started. 30,000 IU urokinase dissolved in 3 ml normal saline was injected into the subarachnoid space, 3 ml normal saline was rinsed into the tube, and the tube was clamped for observation for 2 hours, once a day, for 3 consecutive days. Lumbar cisternae drainage Cerebrospinal fluid is slowly and steadily drained at a rate of less than 8ml/h per hour, the daily drainage volume is not more than 200 ml, and the drainage time of lumbar cisternae is controlled within 7 to 10 days, not more than 14 days.

DRUG

Placebo

On the basis of standard treatment for severe neurological conditions, the treatment of lumbar drainage combined with intrathecal placebo saline injection was started within 24 hours after aneurysm treatment, 3 ml placebo was injected into the subarachnoid space, 3 ml normal saline was flushed into the tube, and the tube was observed for 2 hours, once a day for 3 consecutive days. Lumbar cisternae drainage Cerebrospinal fluid is slowly and steadily drained at a rate of less than 8ml/h per hour, the daily drainage volume is not more than 200 ml, and the drainage time of lumbar cisternae is controlled within 7 to 10 days, not more than 14 days.

Trial Locations (1)

330006

RECRUITING

The Second Affiliated Hospital of Nanchang University, Nanchang

All Listed Sponsors
collaborator

Changhai Hospital

OTHER

lead

Second Affiliated Hospital of Nanchang University

OTHER